86 related articles for article (PubMed ID: 1671001)
1. Scintigraphic detection of overexpressed c-erbB-2 protooncogene products by a class-switched murine anti-c-erbB-2 protein monoclonal antibody.
Saga T; Endo K; Akiyama T; Sakahara H; Koizumi M; Watanabe Y; Nakai T; Hosono M; Yamamoto T; Toyoshima K
Cancer Res; 1991 Feb; 51(3):990-4. PubMed ID: 1671001
[TBL] [Abstract][Full Text] [Related]
2. A murine monoclonal antibody that recognizes an extracellular domain of the human c-erbB-2 protooncogene product.
Masuko T; Sugahara K; Kozono M; Otsuki S; Akiyama T; Yamamoto T; Toyoshima K; Hashimoto Y
Jpn J Cancer Res; 1989 Jan; 80(1):10-4. PubMed ID: 2565325
[TBL] [Abstract][Full Text] [Related]
3. A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16.
Weiner LM; Holmes M; Adams GP; LaCreta F; Watts P; Garcia de Palazzo I
Cancer Res; 1993 Jan; 53(1):94-100. PubMed ID: 8093231
[TBL] [Abstract][Full Text] [Related]
4. Radiolabeled antibody targeting of the HER-2/neu oncoprotein.
De Santes K; Slamon D; Anderson SK; Shepard M; Fendly B; Maneval D; Press O
Cancer Res; 1992 Apr; 52(7):1916-23. PubMed ID: 1348016
[TBL] [Abstract][Full Text] [Related]
5. Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells.
Bacus SS; Stancovski I; Huberman E; Chin D; Hurwitz E; Mills GB; Ullrich A; Sela M; Yarden Y
Cancer Res; 1992 May; 52(9):2580-9. PubMed ID: 1373672
[TBL] [Abstract][Full Text] [Related]
6. Analysis of c-erbB-2 expression in breast carcinomas with clinical follow-up.
Thor AD; Schwartz LH; Koerner FC; Edgerton SM; Skates SJ; Yin S; McKenzie SJ; Panicali DL; Marks PJ; Fingert HJ
Cancer Res; 1989 Dec; 49(24 Pt 1):7147-52. PubMed ID: 2573426
[TBL] [Abstract][Full Text] [Related]
7. Construction of immunoradiometric assay for circulating c-erbB-2 protooncogene product in advanced breast cancer patients.
Hosono M; Saga T; Sakahara H; Kobayashi H; Shirato M; Endo K; Yamamoto T; Akiyama T; Toyoshima K; Konishi J
Jpn J Cancer Res; 1993 Feb; 84(2):147-52. PubMed ID: 8096502
[TBL] [Abstract][Full Text] [Related]
8. In vitro cytotoxic targeting by human mononuclear cells and bispecific antibody 2B1, recognizing c-erbB-2 protooncogene product and Fc gamma receptor III.
Hsieh-Ma ST; Eaton AM; Shi T; Ring DB
Cancer Res; 1992 Dec; 52(24):6832-9. PubMed ID: 1360872
[TBL] [Abstract][Full Text] [Related]
9. An antigen immunologically related to the external domain of gp185 is shed from nude mouse tumors overexpressing the c-erbB-2 (HER-2/neu) oncogene.
Langton BC; Crenshaw MC; Chao LA; Stuart SG; Akita RW; Jackson JE
Cancer Res; 1991 May; 51(10):2593-8. PubMed ID: 1673637
[TBL] [Abstract][Full Text] [Related]
10. Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain Fv.
Adams GP; McCartney JE; Tai MS; Oppermann H; Huston JS; Stafford WF; Bookman MA; Fand I; Houston LL; Weiner LM
Cancer Res; 1993 Sep; 53(17):4026-34. PubMed ID: 7689421
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of internally labeled monoclonal antibodies as a gold standard: comparison of biodistribution of 75Se-, 111In-, and 125I-labeled monoclonal antibodies in osteogenic sarcoma xenografts in nude mice.
Koizumi M; Endo K; Watanabe Y; Saga T; Sakahara H; Konishi J; Yamamuro T; Toyama S
Cancer Res; 1989 Apr; 49(7):1752-7. PubMed ID: 2924318
[TBL] [Abstract][Full Text] [Related]
12. Requirements for the internalization of a murine monoclonal antibody directed against the HER-2/neu gene product c-erbB-2.
Maier LA; Xu FJ; Hester S; Boyer CM; McKenzie S; Bruskin AM; Argon Y; Bast RC
Cancer Res; 1991 Oct; 51(19):5361-9. PubMed ID: 1680547
[TBL] [Abstract][Full Text] [Related]
13. The presence of c-erbB-2 gene product-related protein in culture medium conditioned by breast cancer cell line SK-BR-3.
Alper O; Yamaguchi K; Hitomi J; Honda S; Matsushima T; Abe K
Cell Growth Differ; 1990 Dec; 1(12):591-9. PubMed ID: 1981143
[TBL] [Abstract][Full Text] [Related]
14. Tumor retention of 186Re-MAG3, 111In-DTPA and 125I labeled monoclonal antibody G250 in nude mice with renal cell carcinoma xenografts.
Steffens MG; Kranenborg MH; Boerman OC; Zegwaart-Hagemeier NE; Debruyne FM; Corstens FH; Oosterwijk E
Cancer Biother Radiopharm; 1998 Apr; 13(2):133-9. PubMed ID: 10850349
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo properties of human/mouse chimeric monoclonal antibody specific for common acute lymphocytic leukemia antigen.
Saga T; Endo K; Koizumi M; Kawamura Y; Watanabe Y; Konishi J; Ueda R; Nishimura Y; Yokoyama M; Watanabe T
J Nucl Med; 1990 Jun; 31(6):1077-83. PubMed ID: 2348236
[TBL] [Abstract][Full Text] [Related]
16. Radiolocalization of human small cell lung cancer and antigen-positive normal tissues using monoclonal antibody LS2D617.
Wilson BS; Petrella E; Lowe SR; Lien K; Mackensen DG; Gridley DS; Stickney DR
Cancer Res; 1990 May; 50(10):3124-30. PubMed ID: 2159374
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoimaging of human bladder tumor xenografts in nude mice by using monoclonal antibodies.
Sakahara H; Endo K; Koizumi M; Nakashima T; Okada K; Yoshida O; Masuko T; Hashimoto Y; Torizuka K
Jpn J Cancer Res; 1986 Sep; 77(9):916-21. PubMed ID: 3095288
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic.
Shepard HM; Lewis GD; Sarup JC; Fendly BM; Maneval D; Mordenti J; Figari I; Kotts CE; Palladino MA; Ullrich A
J Clin Immunol; 1991 May; 11(3):117-27. PubMed ID: 1679763
[TBL] [Abstract][Full Text] [Related]
19. Therapy of an animal model of human gastric cancer using a combination of anti-erbB-2 monoclonal antibodies.
Kasprzyk PG; Song SU; Di Fiore PP; King CR
Cancer Res; 1992 May; 52(10):2771-6. PubMed ID: 1349849
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, biodistribution, and gamma camera imaging of 111In-KC-4G3 murine monoclonal antibody in athymic nude mice with or without human tumor xenografts.
Longley C; Furmanski P; Dienhart DG; Lear J; Bloedow D; Kasliwal R; Bunn PA
Cancer Res; 1990 Sep; 50(18):5954-61. PubMed ID: 2393864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
